Kinuya Seigo

Research keywords (4)：内用療法 , 放射性医薬品 , radionuclide therapy , Nuclear Medicine

Research theme for competitive and other funds (25)：

2022 - 2026 細胞内レドックス制御を司るがん幹細胞治療の標的トランスポーター画像診断薬の開発
2022 - 2026 原発性アルドステロン症における新治療戦略ー安全かつ高奏功な根本治療の開発
2019 - 2022 Development of new therapeutoc strategy for high-risk chemotherapy-refractory neuroblastoma
2016 - 2019 Establishment of therapeutic strategy for advanced gastrointestinal cancer with targeted alpha therapy
2013 - 2017 Olfactory training in daily diet and imaging analysis for the olfactory nerve regeneration.

2010 - 2015 Targeted radionuclide therapy for malignant neuroendcrine tumors based on biological and pathohistological characteristics

2009 - 2012 Objective olfactory function test with olfactory nerve transport

2008 - 2011 Evaluation of radiotoxicity to lymphocytes after Yttrium-90-labelled monoclonal anti-CD20 antibody therapy

2007 - 2009 Targeted radionuclide therapy for malignant neuroendcrine tumors combined with antiangiogenic therapy : from bench to bedside

2007 - 2009 腫瘍血管新生の可視化を可能にする分子イメージング剤の開発

2007 - 2008 Development and evaluation of novel radiopharmaceuticals which are targeted to sigma receptors for comprehensive cancer therapy

2006 - 2008 Prediction of cancer therapeutic effect with molecular targeting agents by molecular imaging of the signal transduction

2005 - 2007 Radiotoxicity after iodine-131 MIBG therapy using the micronucleus assay

2005 - 2007 ぽすとFDGを担う腫瘍診断用ポジトロン放出核種標識人工アミノ酸製剤の探索

2004 - 2006 The foundational research on "cancer therapy guideline and effect prediction" by the molecular imaging.

2004 - 2006 Development of specific, universal targeted radiotherapy through induction of avidin on cancer cell membrane and internalization of scavenger receptor

2003 - 2005 transporter遺伝子導入による腫瘍の内照射療法および核医学画像診断の開発

2002 - 2004 腫瘍内アミノ酸・アミン代謝を利用した癌の内部照射治療薬剤の検索

2002 - 2003 Suppression of metastatic lesions of cancer with cooperative effects of internal radiotherapy and antiangiogenic therapy

2001 - 2003 Fundamental Study on objective diagnosis and therapy effect decision of the dementia by the molecular imaging.

2000 - 2001 Enhancement of antitumor effect of internal radiotherapy by inhibition of DNA repair and improvement of intratumoral oxygenation

1997 - 1998 腫瘍血行動態改善による放射能標識モノクローナル抗体の腫瘍治療効果増強に関する研究

1996 - 1996 腫瘍血行動態改善による放射能標識モノクローナル抗体の腫瘍集積性増幅に関する研究

放射性医薬品による腫瘍診断,治療に関する研究

Tumor detection and treatment with radiopharmaceuticals

Show all

Papers (423)：

Kazuma Ogawa, Kota Nishizawa, Kenji Mishiro, Masayuki Munekane, Takeshi Fuchigami, Hiroaki Echigo, Hiroshi Wakabayashi, Seigo Kinuya. Differences in the Renal Accumulation of Radiogallium-Labeled (Glu)14 Peptides Containing Different Optical Isomers of Glutamic Acid. Molecules (Basel, Switzerland). 2024. 29. 17
Hiroshi Mori, Hiroshi Wakabayashi, Shintaro Saito, Kenichi Nakajima, Kotaro Yoshida, Tomo Hiromasa, Seigo Kinuya. Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma. Scientific Reports. 2024. 14. 1
Kenichi Nakajima, Takeshi Matsumura, Junji Komatsu, Hiroshi Wakabayashi, Kenjiro Ono, Seigo Kinuya. Sympathetic 123I-metaiodobenzylguanidine index for Lewy body disease: probability-based diagnosis and identifying patients exempt from late imaging. Annals of Nuclear Medicine. 2024. 38. 10. 814-824
Shintaro Saito, Kenichi Nakajima, Junji Komatsu, Takayuki Shibutani, Hiroshi Wakabayashi, Hiroshi Mori, Aki Takata, Kenjiro Ono, Seigo Kinuya. Absolute quantitation of sympathetic nerve activity using [123I] metaiodobenzylguanidine SPECT-CT in neurology. EJNMMI Reports. 2024. 8. 1
Anri Inaki, Atsushi Mizokami, Hiroshi Wakabayashi, Kouji Izumi, Yoshifumi Kadono, Tadashi Toyama, Shizuko Takahara, Toshinori Murayama, Seigo Kinuya. Evaluation of 68Ga-PSMA-11 PET/CT: a Phase 1 clinical study in Japanese patients with primary, recurrent, or suspected recurrent prostate cancer. Annals of nuclear medicine. 2024

ｍore...

MISC (599)：

萱野大樹, 廣正智, 若林大志, 稲木杏吏, 渡辺悟, 森博史, 赤谷憲一, 山瀬喬史, 國田優志, 松村武史, et al. 褐色細胞腫・傍神経節腫に対するLu-177DOTATATE治療:当院での初期経験. 核医学(Web). 2023. 60. Supplement
赤谷憲一, 若林大志, 廣正智, 山瀬喬史, 國田優志, 渡辺悟, 森博史, 萱野大樹, 絹谷清剛. 分化型甲状腺癌の肺転移病変における123Iシンチグラフィと131Iシンチグラフィの比較. 核医学(Web). 2023. 60. Supplement
張雪, 小西貴広, 若林大志, 米山寛人, 稲木杏吏, 廣正智, 渡辺悟, 森博史, 赤谷憲一, 山瀬喬史, et al. ¹⁷⁷Lu-DOTATATEシンチグラフィによる標的臓器体積測定:CTとの比較. 断層映像研究会雑誌(Web). 2022. 49. 2
赤谷憲一, 若林大志, 高田亜希, 廣正智, 稲木杏吏, 萱野大樹, 絹谷清剛. 甲状腺癌肺転移の長期的予後及び予後因子について. 核医学(Web). 2022. 59. Supplement
稲木杏吏, 若林大志, 廣正智, 森博史, 赤谷憲一, 斉藤晋太郎, 山瀬喬史, 萱野大樹, 絹谷清剛. 金沢大学附属病院におけるLu-177 DOTATATE核医学治療の初期経験. 核医学(Web). 2022. 59. Supplement

ｍore...

Works (1)：

血球標識自動製剤化装置の有用性の検討
2002 -

Education (4)：

- 1990 Kanazawa University
- 1990 Kanazawa University Graduate School, Division of Medicine
- 1986 Kanazawa University
- 1986 Kanazawa University Faculty of Medicine

Professional career (1)：

医学博士

Awards (8)：

2002 - 欧州核医学会誌最優秀科学論文賞
2002 - Best Science Paper in European Journal of Nuclear Medicine
2000 - 佐川がん研究助成金
2000 - 第二回日本核医学会奨励賞
2000 - 優秀論文賞(欧州核医学会議)

Show all

Association Membership(s) (8)：

日本医学放射線学会 , 日本癌学会 , Society of Nuclear Medicine , 日本核医学会 , Asia Oceania Federation of Nuclear Medicine and Biology , 日本内分泌学会 , 日本甲状腺学会 , 日本内分泌外科学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page